David Roth, Chief Medical Officer at Syros Pharmaceuticals, Inc. (SYRS), sold 12,099 shares at $0.20 ($2K) on 2024-11-18, disclosed to the SEC on 2024-11-20.
Open-market sale of $2k SYRS by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| SYRS | SELL | 2023-12-14 | $31K | — | Filing → |
| SYRS | SELL | 2023-12-08 | $25K | — | Filing → |
| SYRS | SELL | 2023-08-02 | $29K | — | Filing → |